(0.16%) 5 162.75 points
(0.12%) 38 880 points
(0.12%) 18 023 points
(0.92%) $78.83
(0.56%) $2.15
(1.00%) $2 331.60
(2.60%) $27.39
(0.55%) $970.60
(0.03%) $0.929
(-0.26%) $10.85
(-0.18%) $0.796
(0.16%) $91.60
-0.14% KRW 71 900
Live Chart Being Loaded With Signals
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 151 677 |
Średni wolumen | 516 239 |
Kapitalizacja rynkowa | 5 285.46B |
EPS | KRW0 ( 2024-04-30 ) |
Następna data zysków | ( KRW355.99 ) 2024-07-26 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW99.33 (0.14%) |
Wolumen Korelacja
Yuhan Corporation Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Yuhan Corporation Korelacja - Waluta/Towar
Yuhan Corporation Finanse
Annual | 2023 |
Przychody: | KRW1 858.98B |
Zysk brutto: | KRW595.83B (32.05 %) |
EPS: | KRW1 815.36 |
FY | 2023 |
Przychody: | KRW1 858.98B |
Zysk brutto: | KRW595.83B (32.05 %) |
EPS: | KRW1 815.36 |
FY | 2022 |
Przychody: | KRW1 775.85B |
Zysk brutto: | KRW518.20B (29.18 %) |
EPS: | KRW1 265.47 |
FY | 2021 |
Przychody: | KRW1 687.81B |
Zysk brutto: | KRW524.65B (31.08 %) |
EPS: | KRW1 595.92 |
Financial Reports:
No articles found.
Yuhan Corporation
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej